Cardiovascular toxicities associated with novel cellular immune therapies
Abstract: Over the past decade, T-cell–directed therapies, including chimeric antigen receptor T-cell (CAR-T) and bispecific T-cell engager (BTE) therapies, have reshaped the treatment of an expanding number of hematologic malignancies, whereas tumor-infiltrating lymphocytes, a recently approved cel...
Збережено в:
| Автори: | , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Elsevier
2024-12-01
|
| Серія: | Blood Advances |
| Онлайн доступ: | http://www.sciencedirect.com/science/article/pii/S2473952924006141 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|